Finance

Beta
Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
₹635.50
+2.53%
(+15.70) 1D
Jun 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
₹625.00
High
₹649.00
Low
₹618.00
Mkt. cap
12.76B
Avg. vol.
244.14K
Volume
114.24K
P/E ratio
14.48
52-wk high
₹770.00
52-wk low
₹440.00
EPS
₹43.88
Shares outstanding
20.00M
No. of employees
2K
Open
₹625.00
High
₹649.00
Low
₹618.00
Mkt. cap
12.76B
Avg. vol.
244.14K
Volume
114.24K
P/E ratio
14.48
52-wk high
₹770.00
52-wk low
₹440.00
EPS
₹43.88
Shares outstanding
20.00M
No. of employees
2K
News stories
From sources across the web
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1.85K
Founded1979
Headquarters-
SectorPharmaceutical industry
Websitelincolnpharma.com
Last report
May 28, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.87B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.54B
1.63B
1.66B
1.87B
Cost of goods sold
693.84M
767.46M
759.60M
890.70M
Cost of revenue
693.84M
767.46M
759.60M
890.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
317.57M
303.56M
306.18M
324.58M
Operating expense
643.55M
648.09M
704.87M
770.35M
Total operating expenses
1.34B
1.42B
1.46B
1.66B
Operating income
203.27M
218.09M
198.75M
211.72M
Other non operating income
152.72M
72.32M
151.46M
-41.95M
EBT including unusual items
353.89M
288.11M
347.22M
167.03M
EBT excluding unusual items
353.89M
288.11M
347.22M
167.03M
Income tax expense
77.14M
88.27M
61.22M
50.68M
Effective tax rate
21.80%
30.64%
17.63%
30.34%
Other operating expenses
291.21M
308.34M
361.49M
408.94M
Net income
276.75M
199.84M
286.00M
116.35M
Net profit margin
17.96%
12.23%
17.20%
6.21%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.10M
-2.31M
-2.98M
-2.74M
Net interest expenses
-2.10M
-2.31M
-2.98M
-2.74M
Depreciation and amortization charges
34.77M
36.19M
37.21M
36.83M
EBITDA
235.52M
253.58M
230.69M
243.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer